Gene name | Average log2 fold change | Adjusted P value |
GIMAP7 | 0.444456 | 0.000791 |
CX3CR1 | 0.370523 | 1.54E-10 |
H3F3B | −0.25528 | 0.008194 |
EIF3H | −0.27161 | 0.000524 |
RPL7 | −0.27724 | 0.008482 |
BTG1 | −0.29421 | 1.80E-08 |
CD74 | −0.32504 | 5.67E-05 |
HLA.DRB1 | −0.3366 | 0.000357 |
CD69 | −0.35405 | 0.004314 |
NFKBIA | −0.35952 | 0.006542 |
TSC22D3 | −0.36775 | 1.30E-05 |
CD3D | −0.41581 | 0.000151 |
TNFAIP3 | −0.42138 | 0.004851 |
DUSP1 | −0.42501 | 3.43E-05 |
LTB | −0.53388 | 7.39E-10 |
ZFP36 | −0.55201 | 2.21E-13 |
IL7R | −0.69229 | 1.54E-17 |
DUSP2 | −0.76309 | 3.16E-20 |
CXCR4 | −0.79897 | 3.37E-29 |
Log2 fold change, positive values indicate that the gene is more highly expressed in the patient who had a stroke compared with controls; adjusted p values are calculated based on Bonferroni correction.